Medcolcanna Organics Inc (TSE:MCCN)
CNQX:MCCN
Canadian Market
Holding TSE:MCCN?
Track your performance easily

Medcolcanna Organics Inc (MCCN) Income Statement

0 Followers

Medcolcanna Organics Inc Income Statement

Last quarter (Q3 2021), Medcolcanna Organics Inc's total revenue was C$156.39K, an increase of 200.80% from the same quarter last year. In Q3, Medcolcanna Organics Inc's net income was C$-2.13M. See Medcolcanna Organics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 20Dec 19Dec 18Dec 17
Total Revenue
C$ 316.61KC$ 95.77KC$ 1.58K--
Cost of Revenue
C$ 1.95MC$ 957.97KC$ 5.35K--
Gross Profit
C$ -1.63MC$ -862.19KC$ -3.77K--
Operating Expense
C$ 4.32MC$ 6.00MC$ 6.88MC$ 165.78KC$ 178.63K
Operating Income
C$ -5.95MC$ -6.86MC$ -6.88MC$ -165.78KC$ -178.63K
Net Non Operating Interest Income Expense
C$ 751.32KC$ 297.90KC$ 56.78K--
Other Income Expense
C$ 205.22KC$ -272.61KC$ -277.85KC$ -2.43KC$ -2.42K
Pretax Income
C$ -6.49MC$ -7.43MC$ -7.21MC$ -168.21KC$ -181.05K
Tax Provision
C$ -69.39KC$ -69.39K---
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
C$ -6.35MC$ -7.27MC$ -7.21MC$ -168.21KC$ -181.05K
Basic EPS
C$ -0.07C$ -0.08---
Diluted EPS
C$ -0.07C$ -0.08---
Basic Average Shares
C$ 409.78MC$ 95.42M---
Diluted Average Shares
C$ 409.78MC$ 95.42M---
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
C$ -6.26MC$ -6.96MC$ -6.88MC$ -165.78KC$ -178.63K
Net Income From Continuing And Discontinued Operation
C$ -6.35MC$ -7.27MC$ -7.21MC$ -168.21KC$ -181.05K
Normalized Income
C$ -4.41MC$ -7.18MC$ -5.10MC$ -121.20KC$ -117.84K
Interest Expense
-----
EBIT
C$ -5.76MC$ -7.16MC$ -7.16MC$ -168.21KC$ -181.05K
EBITDA
C$ -4.76MC$ -6.99MC$ -6.98MC$ -164.13KC$ -175.62K
Currency in CAD

Medcolcanna Organics Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis